Patient preferences for treatment of metastatic breast cancer: a study of women with early-stage breast cancer.

Abstract

Patients showed clear preferences for specific treatments for metastatic disease when given hypothetical scenarios. There was a wide range of patient preferences for treatment based on risk-benefit assessment, but a substantial percentage of patients would accept the risk of major toxicity for minimal increase in overall survival.